Sanofi Ready To Pull The Plug On Regeneron 'Life Support'
Executive Summary
Global R&D President Elias Zerhouni said Sanofi has the knowledge and skills it needs to discover antibody drugs internally and it's time to end the perception that Regeneron is keeping Sanofi's R&D humming.
You may also be interested in...
What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About
Sanofi's Nestle talked to Scrip about the company's early pipeline, the emerging technologies he thinks are most promising and tapping external innovation.
What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About
Sanofi's Nestle talked to In Vivo about the company's early pipeline, the emerging technologies he thinks are most promising, and tapping external innovation.
Sanofi R&D Chief Elias Zerhouni On Partnerships, Drug Targets, And Market Dynamics
As he steps down after a nine-year run as head of R&D, Zerhouni discusses the lessons he's learned and his major accomplishments.